To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses click here.
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
COVID-19 Treatment Updates: Focus on Monoclonal Antibodies and Tocilizumab
• Lindsey R. Baden, MD
Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Division of Infectious Diseases
Brigham and Women's Hospital
• Rajesh Gandhi, MD, FIDSA
Director, HIV Clinical Services and Education
Massachusetts General Hospital
Co-Director, Harvard Center for AIDS Research
Professor of Medicine, Harvard Medical School
Chair, HIV Medicine Association
• John O’Horo, MD, MPH, FACP
Consultant, Division of Infectious Diseases
Joint Appointment Division of Pulmonary and Critical Care Medicine
Associate Professor of Medicine
Mayo Clinic College of Medicine
• John Farley, MD, MPH
Director of the Office of Infectious Diseases
US Food and Drug Administration
